These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33906182)

  • 21. Eight-hours adaptive deep brain stimulation in patients with Parkinson disease.
    Arlotti M; Marceglia S; Foffani G; Volkmann J; Lozano AM; Moro E; Cogiamanian F; Prenassi M; Bocci T; Cortese F; Rampini P; Barbieri S; Priori A
    Neurology; 2018 Mar; 90(11):e971-e976. PubMed ID: 29444973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep Brain Stimulation Can Differentiate Subregions of the Human Subthalamic Nucleus Area by EEG Biomarkers.
    Sand D; Arkadir D; Abu Snineh M; Marmor O; Israel Z; Bergman H; Hassin-Baer S; Israeli-Korn S; Peremen Z; Geva AB; Eitan R
    Front Syst Neurosci; 2021; 15():747681. PubMed ID: 34744647
    [No Abstract]   [Full Text] [Related]  

  • 23. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of mild parkinsonism revealed by neural oscillatory changes and machine learning.
    Bore JC; Campbell BA; Cho H; Gopalakrishnan R; Machado AG; Baker KB
    J Neurophysiol; 2020 Dec; 124(6):1698-1705. PubMed ID: 33052766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Entropy of Adaptively Segmented Beta Oscillations Predict Motor Improvement in Patients With Parkinson's Disease.
    Velasco S; Branco L; Abosch A; Ince NF
    IEEE Trans Biomed Eng; 2022 Jul; 69(7):2333-2341. PubMed ID: 35025735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.
    Piboolnurak P; Lang AE; Lozano AM; Miyasaki JM; Saint-Cyr JA; Poon YY; Hutchison WD; Dostrovsky JO; Moro E
    Mov Disord; 2007 May; 22(7):990-7. PubMed ID: 17443692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compensatory stepping in Parkinson's disease is still a problem after deep brain stimulation randomized to STN or GPi.
    St George RJ; Carlson-Kuhta P; King LA; Burchiel KJ; Horak FB
    J Neurophysiol; 2015 Sep; 114(3):1417-23. PubMed ID: 26108960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subthalamic oscillatory activities at beta or higher frequency do not change after high-frequency DBS in Parkinson's disease.
    Foffani G; Ardolino G; Egidi M; Caputo E; Bossi B; Priori A
    Brain Res Bull; 2006 Mar; 69(2):123-30. PubMed ID: 16533660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical neurophysiological interrogation of motor slowing: A critical step towards tuning adaptive deep brain stimulation.
    Alva L; Bernasconi E; Torrecillos F; Fischer P; Averna A; Bange M; Mostofi A; Pogosyan A; Ashkan K; Muthuraman M; Groppa S; Pereira EA; Tan H; Tinkhauser G
    Clin Neurophysiol; 2023 Aug; 152():43-56. PubMed ID: 37285747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biophysical basis of subthalamic local field potentials recorded from deep brain stimulation electrodes.
    Maling N; Lempka SF; Blumenfeld Z; Bronte-Stewart H; McIntyre CC
    J Neurophysiol; 2018 Oct; 120(4):1932-1944. PubMed ID: 30020838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus.
    Gulberti A; Moll CK; Hamel W; Buhmann C; Koeppen JA; Boelmans K; Zittel S; Gerloff C; Westphal M; Schneider TR; Engel AK
    Neuroimage Clin; 2015; 9():436-49. PubMed ID: 26594626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single threshold adaptive deep brain stimulation in Parkinson's disease depends on parameter selection, movement state and controllability of subthalamic beta activity.
    Busch JL; Kaplan J; Habets JGV; Feldmann LK; Roediger J; Köhler RM; Merk T; Faust K; Schneider GH; Bergman H; Neumann WJ; Kühn AA
    Brain Stimul; 2024; 17(1):125-133. PubMed ID: 38266773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subthalamic deep brain stimulation improves auditory sensory gating deficit in Parkinson's disease.
    Gulberti A; Hamel W; Buhmann C; Boelmans K; Zittel S; Gerloff C; Westphal M; Engel AK; Schneider TR; Moll CK
    Clin Neurophysiol; 2015 Mar; 126(3):565-74. PubMed ID: 25085452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of dopaminergic therapy on intraoperative microelectrode recordings for subthalamic deep brain stimulation under GA: can we operate on patients 'on medications'?
    Asha MJ; Kausar J; Krovvidi H; Shirley C; White A; Chelvarajah R; Hodson JA; Pall H; Mitchell RD
    Acta Neurochir (Wien); 2016 Feb; 158(2):387-93. PubMed ID: 26602236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subthalamic local field potentials after seven-year deep brain stimulation in Parkinson's disease.
    Giannicola G; Rosa M; Servello D; Menghetti C; Carrabba G; Pacchetti C; Zangaglia R; Cogiamanian F; Scelzo E; Marceglia S; Rossi L; Priori A
    Exp Neurol; 2012 Oct; 237(2):312-7. PubMed ID: 22735488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subthalamic nucleus deep brain stimulation improves dyskinesias in Parkinson's disease beyond levodopa reduction.
    Mossner JM; Patil PG; Chou KL
    J Neural Transm (Vienna); 2019 Nov; 126(11):1479-1483. PubMed ID: 31494731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levodopa-dependent differences in the non-oscillatory activity of the subthalamic nucleus.
    Ferrara R; Bianchi AM; Priori A; Coelli S; Averna A
    Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():2310-2313. PubMed ID: 36086042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pallidal versus subthalamic nucleus deep brain stimulation for levodopa-induced dyskinesia.
    Fan SY; Wang KL; Hu W; Eisinger RS; Han A; Han CL; Wang Q; Michitomo S; Zhang JG; Wang F; Ramirez-Zamora A; Meng FG
    Ann Clin Transl Neurol; 2020 Jan; 7(1):59-68. PubMed ID: 31813194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subthalamic local field potentials in Parkinson's disease and isolated dystonia: An evaluation of potential biomarkers.
    Wang DD; de Hemptinne C; Miocinovic S; Qasim SE; Miller AM; Ostrem JL; Galifianakis NB; San Luciano M; Starr PA
    Neurobiol Dis; 2016 May; 89():213-22. PubMed ID: 26884091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.